LIB THERAPEUTICS
Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...
Ulta-pulta latkana, don't try it at home'Ulta latka kar sidha karna' as a potential therapeutic technique for back pain, cautioning against its risks like increased blood pressure...
- Load More